Long-term observation study for maxillary sinus floor augmentation using octa-calcium phosphate/collagen composite

Long-term observation study for maxillary sinus floor augmentation using octa-calcium phosphate/collagen composite - Long-term observation for maxillary sinus floor augmentation using OCP/collagen

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041464

Enrollment

Registered

2020-09-01

Start date

2020-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alveolar bone atrophy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were included in the clinical trial "a multi-center single arm clinical trial of bone regenerative material; OCP/Col"

Exclusion criteria

Exclusion criteria: Patients who are treated for bone metabolic diseases such as osteoporosis and who are taking bisphosphonate drugs

Design outcomes

Primary

Measure	Time frame
Dental implant status (infection, peri-implantitis, dental implant stability, pain, paresthesia) 5 years after maxillary sinus floor augmentation using OCP/Col composite	—

Secondary

Measure	Time frame
CT value (HU unit), vertical bone hight, new bone volume 5 years after maxillary sinus floor augmentation using OCP/Col composite	—

Countries

Japan

Contacts

Public ContactIzumi Asahina

Nagasaki University Hospital Oral Surgery

asahina@nagasaki-u.ac.jp095-819-7701

Outcome results